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Abstract
Proximal tubule epithelial cells (PTEC) of the kidney line the proximal tubule downstream of
the glomerulus and play a major role in the re-absorption of small molecular weight proteins
that may pass through the glomerular filtration process. In the perturbed disease state
PTEC also contribute to the inflammatory disease process via both positive and negative
mechanisms via the production of inflammatory cytokines which chemo-attract leukocytes
and the subsequent down-modulation of these cells to prevent uncontrolled inflammatory
responses. It is well established that dendritic cells are responsible for the initiation and
direction of adaptive immune responses. Both resident and infiltrating dendritic cells are
localised within the tubulointerstitium of the renal cortex, in close apposition to PTEC, in
inflammatory disease states. We previously demonstrated that inflammatory PTEC are able
to modulate autologous human dendritic cell phenotype and functional responses. Here we
extend these findings to characterise the mechanisms of this PTEC immune-modulation
using primary human PTEC and autologous monocyte-derived dendritic cells (MoDC) as
the model system. We demonstrate that PTEC express three inhibitory molecules: (i) cell
surface PD-L1 that induces MoDC expression of PD-L1; (ii) intracellular IDO that maintains
the expression of MoDC CD14, drives the expression of CD80, PD-L1 and IL-10 by MoDC
and inhibits T cell stimulatory capacity; and (iii) soluble HLA-G (sHLA-G) that inhibits HLA-
DR and induces IL-10 expression by MoDC. Collectively the results demonstrate that pri-
mary human PTEC are able to modulate autologous DC phenotype and function via multi-
ple complex pathways. Further dissection of these pathways is essential to target
therapeutic strategies in the treatment of inflammatory kidney disorders.
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Introduction
Proximal tubule epithelial cells (PTEC) of the kidney line the proximal tubule downstream of
the glomerulus where one of their major physiological roles is the re-absorption of small
molecular weight proteins, peptides and glucose via receptors present on the villi of their lumi-
nal surface. This localisation and biological role exposes PTEC to numerous challenging stimuli
in the event of any up-stream pathology, with excessive protein, glucose, toxins, advanced gly-
cation end products (AGEs) and bacterial products all being able to perturb normal PTEC
physiology [1–3]. In this perturbed state, PTEC are thought to be central players in the disease
process, where they alter their gene transcription profiles [4] and secrete a range of chemoat-
tractant cytokines to recruit immune cells into the interstitium of the kidney [5]. In addition to
such changes, we have recently published that these PTEC are also able to modulate autologous
immune-cell phenotype and function [6–8].
Dendritic cells (DC) are a powerful population in the innate immune system. They are pro-
fessional antigen presenting cells (APC) that, following activation in the presence of danger sig-
nals, induce and regulate adaptive immune responses. Triggering of DC leads to the up-
regulation of co-stimulatory (CD80, CD86) and inhibitory (PD-L1) molecules, production of
pro-inflammatory (IL-12) and regulatory (IL-10) cytokines and priming of T cell responses
[9].
In humans, two subclasses of DC that have been frequently reported within diseased kidney
are (i) monocyte-derived DC (MoDC), an inflammatory DC population that rapidly develop
from blood monocytes in response to inflammation and infection and (ii) CD1c+ DC, a promi-
nent subclass of the myeloid DC lineage [5, 10–12]. In all of these studies, DC were reported as
being primarily localised to the interstitium, with minimal to no evidence for their homing to
the glomerular compartment. The restricted localisation of infiltrating DC to the interstitium
positions them to receive the signals of activated PTEC. Indeed, we have published that human
PTEC are able to modulate autologous MoDC and CD1c+ DC surface antigen (Ag) expression,
Ag-uptake, cytokine expression and T cell stimulatory function. [7].
In this current report we extend these findings to characterise the mechanisms of PTEC
modulation of DC phenotype and function using primary human PTEC and autologous
MoDC as the model system. We focus, in particular, on cell surface-expressed PD-L1, soluble
HLA-G (sHLA-G) and intracellular indoleamine-2,3-dioxygenase (IDO) molecules expressed
by primary human PTEC, as we have recently demonstrated their immuno-regulatory effects
on autologous T and B lymphocytes [6, 8].
Materials andmethods
Subjects
Kidney tissue from the healthy portion of malignant and non-malignant nephrectomies and
peripheral blood from these same donors three to six months post-nephrectomy were obtained
following written informed consent under approval by the Queensland Institute of Medical
Research (P293) and Royal Brisbane andWomen’s Hospital (2002/011) Ethics Committees.
Isolation and culture of PTEC
Cortex tissue was dissected from macroscopically/microscopically normal portions of the kid-
ney and processed for PTEC purification within one hour. PTEC were purified following the
method of Glynne and Evans [13] and cultured in Defined Medium (DM). DM comprised a
1:1 mixture of Dulbecco’s Modified Eagle’s Medium and Ham’s F12 containing 15mMHEPES
buffer, L-glutamine and pyridoxine hydrochloride (Invitrogen, Grand Island, NY, USA). The
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medium was supplemented with epidermal growth factor (10 ng/ml), insulin (10 μg/ml), trans-
ferrin (5 μg/ml), selenium (5 ng/ml), hydrocortisone (36 ng/ml), triiodothyronine (4 pg/ml),
penicillin (50 U/ml) and streptomycin (50 mg/ml). Cell stocks were frozen at passage 1 (P1)
and all PTEC used in experiments were at P2 or P3. PTEC were characterised on the basis of:
1) strong staining for cytokeratin-18, 2) strong staining for alkaline phosphatase activity using
the naphtal AS-MX method and 3) characteristic cobblestone morphology.
Activation of PTEC
PTEC were cultured in DM until 70–80% confluence. As previously established [7], PTEC
were then exposed to 100ng/ml interferon (IFN)-γ (R&D Systems, Minneapolis, MN, USA) for
24 hours to recapitulate the inflammatory disease setting. To prevent further proliferation,
PTEC were irradiated with 3000cGy prior to co-culture with monocytes.
MoDC generation and culture
Peripheral blood mononuclear cells (PBMC) were isolated using Ficoll-Paque Plus density gra-
dient centrifugation (GE Healthcare, Uppsala, Sweden). Monocytes were isolated from PBMC
by CD14+ immuno-magnetic selection (>95% purity) (Mitenyi Biotec, Bergisch Gladbach,
Germany) according to the manufacturer’s instructions. For differentiation into MoDC, puri-
fied monocytes were cultured for 5 days in Complete Medium (CM) consisting of RPMI 1640,
containing 10% heat-inactivated human AB serum, 100U/ml penicillin, 100μg/ml streptomy-
cin, 2mM L-glutamine, 1mM sodium pyruvate, 0.1mM non-essential amino acids, 10mM
HEPES buffer solution (all from Invitrogen), and 50μM 2-mercaptoethanol (Sigma-Aldrich, St
Louis, MO, USA) and supplemented with 800U/ml GM-CSF (Miltenyi Biotec) and 1000U/ml
IL-4 (Miltenyi Biotec). Cultures were established in either; standard 24-well plates for contact-
dependant (CD) cultures or 0.4μM transwell 24 well plates for contact-independent (CI) cul-
tures, alone (Ctrl-MoDC) or in the presence of IFN-γ-activated, irradiated PTEC
(PTEC-MoDC).
Blocking studies
For programmed death ligand-1 (PD-L1) blocking, 10 μg/mL of anti-human PD-L1 (Biole-
gend, clone 29E.2A3, San Diego, CA, USA) blocking antibody was added to the surface of
PTEC and incubated for 2 h. Following incubation, the PTEC wells were extensively washed
with 5 changes of warm CM to remove all traces of unbound antibody and the co-cultures
were established. To neutralise soluble human leukocyte antigen-G (sHLA-G) and IDO, 10 μg/
mL of anti-human sHLA-G (Biolegend, clone 87G) blocking antibody and 1500 μM/mL IDO
inhibitor 1-methyl-tryptophan (1-MT) (Life Technologies, CA, USA) respectively was added
into the PTEC or control wells immediately following co-culture establishment. The effective
blocking concentration levels of 1-MT were determined via titration using cell viability and
tryptophan-kynurenine ratios monitored by HPLC (data not shown).
Flow cytometry phenotyping
Cells were labelled with combinations of PE-, FITC-, PerCP-, APC-, PE-Cy7-, V450- and
Pacific Orange-conjugated mouse anti-human CD14, CD80, CD86, DC-SIGN (CD209) (all
from BD Biosciences, Franklin Lakes, NJ, USA), PD-L1 (CD274) (Biolegend) and HLA-DR
(Invitrogen) antibodies and appropriate isotype controls, using 0.25 μg of each antibody per
staining reaction. Acquisition was performed on a BD FACSCanto II flow cytometer (BD Bio-
sciences) and analysis of flow data was performed using FlowJo 7.6.4 (Tree Star, Inc., Ashland,
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OR, USA). For viability staining, cells were labelled with a Near-IR dead cell stain kit (Invitro-
gen) according to the manufacturer’s instructions and analysed by flow cytometry.
Cytokine secretion assays
Culture supernatants were harvested and levels of IL-10 and IL-12p70 were determined using
Flow Cytometric Bead Arrays (BD Biosciences) according to the manufacturer’s instructions.
Allogeneic MLR
Allogeneic CD4+ T cells were isolated from PBMC by negative immuno-magnetic selection
using the CD4+ T cell isolation kit II (>95% purity) (Miltenyi Biotec). MoDC separated from
PTEC, were plated in triplicate in 96-well plates at 1:2 serial dilutions starting at 2.5x104 cells/
well. Allogeneic CD4+ T cell responders were added at 1x105 cells/well. Cells were cultured for
5 days and proliferation was assessed by the addition of 1μCi 3H-thymidine/well (Perkin
Elmer, Boston, MA, USA) for the last 8 hours of culture.
Statistical Analysis
Comparisons between two groups were performed using a two-tailed Wilcoxon signed rank
test. Statistical tests were performed using GraphPad Prism 5.0 analysis software (GraphPad,
San Diego, CA, USA). P values0.05 were considered statistically significant.
Results
We first undertook contact-dependent and transwell contact-independent parallel co-culture
experiments to establish whether PTEC modulation of autologous DC phenotype and function
operated through contact or soluble mechanisms.
Autologous PTECmodulate the MoDC expression of HLA-DR, CD86
and CD80 by contact independent mechanisms and CD14 and PD-L1
by both contact dependent and contact independent mechanisms
In both CD and CI culture systems the progression of CD14+ monocyte differentiation into
MoDC was confirmed by the expression of the DC marker DC-SIGN (Fig 1A) in both the
absence and presence of PTEC. The expression of CD14 was retained at elevated levels by
PTEC-MoDC when compared with Ctrl-MoDC from both CD and CI culture systems but the
level of CD14 was considerably less on PTEC-MoDC in the CI culture system when compared
with PTEC-MoDC from the CD culture system (Fig 1B). The expression of HLA-DR was
down regulated by PTEC-MoDC in three out of six donors in the CD culture system and in all
donors from the CI culture system (Fig 1C). The expression of CD86 on PTEC-MoDC was sig-
nificantly down regulated in all donors in both CD and CI culture systems (Fig 1E) and CD80
was upregulated by PTEC-MoDC in four out of six donors in the CD system and in five out of
six donors in the CI system, when compared with Ctrl-MoDC (Fig 1D). The expression of
PD-L1 was up regulated on PTEC-MoDC in both CD and CI culture systems, but this up-regu-
lation was only significant (p = 0.03) in the CD culture system (Fig 1F).
Autologous PTECmodulate IL-10 secretion by MoDC through CD
mechanisms
To identify the regulatory mechanism of autologous PTEC on MoDC cytokine secretion, we
analysed the supernatant of Ctrl- and PTEC-MoDC from both CD and CI culture systems.
PTECMechanism of DC Phenotype and Function
PLOS ONE | DOI:10.1371/journal.pone.0134688 July 31, 2015 4 / 13
Fig 1. Expression of surface antigens (A) DC-SIGN, (B) CD14, (C) HLA-DR, (D) CD80, (E) CD86 and (F) PD-L1 by Ctrl- and PTEC-MoDC from CD and
CI culture systems. The bar graph represents mean values (± SEM) for five to seven donors and the line graph represents five to seven individual donor
experiments. Surface expression was measured by flow cytometry (gated on live, single cells) and reported as delta MFI (MFI test-MFI isotype control).
Statistical comparisons between the two groups were performed using a two-tailedWilcoxon signed rank test.
doi:10.1371/journal.pone.0134688.g001
Fig 2. Secretion of anti-inflammatory cytokine IL-10 by Ctrl- and PTEC-MoDC from CD and CI culture systems represented as mean values for five
donors (bar graph) and five individual donor (line graph) experiments as determined using a flow cytometric bead array and presented as pg/mL.
doi:10.1371/journal.pone.0134688.g002
PTECMechanism of DC Phenotype and Function
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PTEC-MoDC secreted elevated levels of IL-10 in all five donors when compared with Ctrl-
MoDC within the CD culture system. However, this increased IL-10 expression was not
observed in the CI culture system (Fig 2). Secretion of pro-inflammatory cytokine IL-12p70
was not detec in any culture system (data not shown).
PTEC-MoDC from both CD and CI culture systems were less effective in
stimulating allogeneic CD4+ T cell responses
The ability to induce proliferation of allogeneic CD4+ T cells in a mixed lymphocyte reaction
(MLR) is one of the definitive features of DC. To identify the mechanism through which autol-
ogous PTEC modulate MoDC to down-regulate allogeneic CD4+ T cell responses, allo-MLR
assays were established utilising Ctrl- and PTEC-MoDC obtained from CD and CI culture sys-
tems. PTEC-MoDC were less effective at stimulating CD4+ T cell responses when compared
with their respective Ctrl-MoDC from both CD and CI culture systems. Although PTEC-
MoDC from CI cultures stimulated higher levels of T cell proliferation compared to PTEC
from CD co-cultures, suggesting a partially contact-mediated mechanism for PTEC suppres-
sion (Fig 3), this failed to reach significance.
Following the elucidation of both CD and CI mechanisms of immune regulation, the mole-
cules participating in these mechanisms were investigated. As we have identified that PTEC
express the immuno-regulatory molecules sHLA-G, PD-L1 and IDO [8], the specific role of
these molecules in modulating MoDC phenotype and function was investigated by blocking
their activity within the PTEC-MoDC co-cultures.
PD-L1 expressed by autologous PTECmediates the expression of
PD-L1 on MoDC but does not impact IL-10 secretion by these cells
PTEC PD-L1 blocking significantly decreased (p = 0.01) PD-L1 expression on PTEC-MoDC
(Fig 4E). The expression of other surface antigens including DC-SIGN (data not shown),
HLA-DR (Fig 4B), CD80 (Fig 4C) and CD86 (Fig 4D) were not influenced by PTEC PD-L1
blocking. Similarly, levels of IL-10 were unaffected by PTEC PD-L1 blocking (Fig 4F) indicat-
ing that PTEC expressed PD-L1 was not involved in the regulation of observed elevated cyto-
kine expression levels.
Fig 3. Allogeneic CD4+ T cell proliferation induced by Ctrl- and PTEC-MoDC from CD and CI cultures in three individual donors (donor 1, donor 2
and donor 3) at 1:8 MoDC:T cell ratio. Proliferation was measured by 3[H]-thymidine incorporation and expressed as counts per minute (CPM) after 5 days.
doi:10.1371/journal.pone.0134688.g003
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sHLA-G expressed by autologous PTEC partly mediates the expression
of HLA-DR on MoDC and the secretion of IL-10 by MoDC
Following differentiation, the Ctrl- and PTEC-MoDC were harvested and stained for surface
antigen expression and the culture supernatants analysed for IL-10 levels. The blocking of
sHLA-G reversed HLA-DR expression on PTEC-MoDC, where two out of three donors dem-
onstrated a partial restoration in the expression of this molecule (Fig 5A). The expression of
CD14, CD80, CD86 and PD-L1 were unaffected by sHLA-G blocking (data not shown).
The levels of IL-10 were partly reduced in all donors in the presence of blocking antibody to
sHLA-G (Fig 5B). This result was somewhat surprising given that our CD/CI experiments indi-
cated a CD mechanism was responsible for the elevated IL-10 fromMoDC in the presence of
INF-γ activated autologous PTEC.
IDO activity of autologous PTEC regulates the expression of CD14,
CD80 and PD-L1 on MoDC and partially regulates the secretion of IL-10
from these cells
Blocking IDO activity in our co-cultures decreased the expression of CD14 in five out of seven
donors (Fig 6A), suggesting greater MoDC differentiation of these cells, and significantly
Fig 4. Expression of surface antigens (A) CD14, (B) HLA-DR, (C) CD80, (D) CD86, (E) PD-L1 and (F) anti-inflammatory cytokine IL-10 by Ctrl-MoDC,
PTEC-MoDC and PTEC-MoDC supplemented with blocking antibody for PD-L1. The bar graph represents mean of eight to nine donors and the line
graph represents individual donor experiments. Surface expression was measured by flow cytometry (gated on live, single cells) and reported as delta MFI
(MFI test-MFI isotype control). Cytokine expression was determined using a flow cytometric bead array and presented as pg/mL.
doi:10.1371/journal.pone.0134688.g004
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down-regulated the expression of CD80 and PD-L1 (Fig 6B and 6C), whilst having no effect on
HLA-DR or CD86 levels (data not shown). Blocking IDO activity in our co-cultures also partly
down-regulated the expression of IL-10 by PTEC-MoDC in six out of seven donors (Fig 6D).
IDO activity of autologous PTEC plays a partial role in regulating the
allogeneic response-inducing function of MoDC
To investigate the functional effects of PTEC inhibitory molecules, we established allogeneic
MLR with PTEC-MoDC that were differentiated in the presence of anti-PD-L1, anti-sHLA-G
and 1-MT respectively. No recovery of allo-stimulatory ability was seen from PTEC-MoDC
that were differentiated in the presence of anti-PD-L1 or anti-sHLA-G (data not shown). How-
ever, we observed partial restoration of CD4+ T cell proliferation in four out of five donors (Fig
7) when PTEC-MoDC were differentiated in the presence of 1-MT, although this restoration
did not achieve significance.
Fig 5. Expression of surface antigen (A) HLA-DR and (B) anti-inflammatory cytokine IL-10 by Ctrl-MoDC, PTEC-MoDC and PTEC-MoDC
supplemented with blocking antibody for sHLA-G. The bar graph represents mean of three donors and the line graph represents individual donor
experiments. Surface expression was measured by flow cytometry (gated on live, single cells) and reported as delta MFI (MFI test-MFI isotype control).
Cytokine expression was determined using a flow cytometric bead array and presented as pg/mL
doi:10.1371/journal.pone.0134688.g005
PTECMechanism of DC Phenotype and Function
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Discussion
As we have previously published [7], the presence of autologous PTEC skew MoDC to become
phenotypically less mature and functionally less stimulatory. In this report we investigated the
mechanisms by which these regulatory steps occur. As an initial step in this process, CD14+
monocytes were differentiated into MoDC in CD or CI culture conditions to identify whether
autologous PTEC regulate MoDC differentiation and function by surface expressed molecules
(CD mechanism) or by soluble factors (CI mechanism).
Fig 6. Expression of surface antigens (A) CD14, (B) CD80, (C) PD-L1 and (F) anti-inflammatory cytokine IL-10 by Ctrl-MoDC, PTEC-MoDC and
PTEC-MoDC supplemented with 1-MT, an inhibitory molecule to suppress the activity of IDO expressed by autologous PTEC. The bar graph
represents mean of seven to ten donors and the line graph represents individual donor experiments. Surface expression was measured by flow cytometry
(gated on live, single cells) and reported as delta MFI (MFI test-MFI isotype control). Cytokine expression was determined using a flow cytometric bead array
and presented as pg/mL.
doi:10.1371/journal.pone.0134688.g006
Fig 7. Allogeneic CD4+ T cell proliferation induced by Ctrl-MoDC, PTEC-MoDC and PTEC-MoDC supplemented with IDO inhibitor 1-MT represented
asmean values for five donors (bar graph) and five individual donors (line graph) at a 1:8 MoDC:T cell ratio. Proliferation was measured by 3[H]-
thymidine incorporation and expressed as counts per minute (CPM) after 5 days.
doi:10.1371/journal.pone.0134688.g007
PTECMechanism of DC Phenotype and Function
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Confirming our previous findings [7], all MoDC differentiated in the presence of autologous
PTEC in CD culture systems phenotypically retained the monocyte marker CD14, expressed
low levels of HLA-DR and CD86 and up-regulated PD-L1. Although the intensity of the
expression of CD14, CD80, CD86, HLA-DR, and PD-L1 on Ctrl- and PTEC-MoDC varied
between CD and CI culture systems, the overall pattern of expression of these molecules sug-
gested that autologous PTEC regulated CD80, CD86 and HLA-DR by CI mechanisms and
CD14 and PD-L1 through both CD and CI mechanisms.
The mechanism/s of autologous PTEC regulation of MoDC function, including their cyto-
kine profiles and their ability to stimulate allogeneic CD4+ T cell responses were also investi-
gated by using Ctrl- and PTEC-MoDC derived from both CD and CI culture systems.
Autologous PTEC up-regulated the expression of IL-10 fromMoDC through a CD mecha-
nism. The allo-MLR assay showed that PTEC-MoDC from both CD and CI culture systems
were less effective at stimulating allogeneic CD4+ T cell proliferation than Ctrl-MoDC. How-
ever, a partial restoration in T cell stimulation by PTEC-MoDC from CI cultures compared to
PTEC-MoDC from CD cultures suggests that autologous PTEC inhibit the allogeneic-inducing
function of MoDC through both CD and CI mechanisms.
Following the identification of CD or CI regulatory mechanisms behind the expression of
phenotypic markers and function of MoDC, molecules participating in these mechanisms were
investigated. The up-regulation of immuno-regulatory molecule PD-L1 on autologous PTEC
was reported in our previous publication [6]. PD-L1 or CD274, is a inhibitory molecule of the
B7 family group which interacts with its receptor PD-1 on monocytes [14], to provide negative
signals via the PD-1 cytoplasmic immuno-receptor tyrosine based inhibitory motif (ITIM)
[15]. PD-L1 is expressed at low to negligible levels in normal kidney but is up-regulated in a
number of kidney diseases, especially within areas of mononuclear cell infiltration [16, 17],
suggesting that cytokines secreted from these infiltrating cells may induce PD-L1 expression
on PTEC in vivo. Our blocking studies indicate that a pivotal role of PTEC-expressed PD-L1 is
to increase the expression of PD-L1 on autologous MoDC. As PD-L1 is surface expressed, it
was logical to conclude that this was one of the primary CD mechanisms responsible for our
observed low T cell stimulatory capacity of PTEC-MoDC. However, our functional PD-L1
blocking studies did not support this assumption.
Our subsequent functional blocking experiments identified IDO as the candidate molecule
responsible for this mechanism. The IFN-γ-inducible intracellular enzyme IDO catalyses the
breakdown of essential amino acid tryptophan into kynurenine and creates a micro-environ-
ment devoid of tryptophan. Tryptophan depletion and the generated kynurenine bi-products
have both been recognised as immune-regulators of antigen presenting cells [18–21]. We have
recently identified that our IFN-γ treated primary PTEC cultures express biologically active
IDO [8]. IDO expression has been demonstrated within the kidney compartment and
increased levels have correlated with improved outcomes in several mouse models of human
kidney disease [22], suggesting this molecule may play a role in dampening inflammatory
responses. However, Mohib et al demonstrated a pathological role for IDO in ischemia-
reperfusion injury [23].
Our results contribute to this apparent dichotomy by demonstrating that PTEC-produced
IDO both up-regulates costimulatory CD80 and inhibitory PD-L1 and regulatory IL-10 on
APC. In addition, our results show that PTEC-expressed IDO plays a role in the retention of
monocyte marker CD14 on developing MoDC, inhibiting complete monocyte-to-MoDC dif-
ferentiation and contributing to our observed weak T cell stimulatory capacity of these cells.
However, it should be noted from our transwell experiments that IL-10 expression from devel-
oping MoDC is contact-dependant, indicating that the soluble effects of tryptophan depletion
PTECMechanism of DC Phenotype and Function
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upon IL-10 induction could be driving an autocrine up-regulation of another, as yet un-
identified, immuno-regulatory surface molecule on PTEC.
Our results also implicated another soluble inhibitory molecule, sHLA-G, in the decreased
expression of HLA-DR and induction of IL-10 fromMoDC. We have demonstrated HLA-G
mRNA and intracellular protein up-regulation in our primary PTEC cultures in response to
IFN-γ stimulation (data not shown), with concomitant increases in sHLA-G from the superna-
tants of these cells [8]. This is in contrast to a previous study by Kronsteiner et al [24] which
reported that PTEC alone do not secrete sHLA-G. However, unlike our study, Kronsteiner et al
did not stimulate PTEC with IFN-γ, which induces the expression of sHLA-G. Functionally,
the role of sHLA-G has been demonstrated to be beneficial in various clinical conditions
including pregnancy, transplantation and various inflammatory diseases [25, 26]. In kidney
models, the presence of HLA-G in renal allograft biopsies [27] and increased sHLA-G levels in
plasma samples from kidney transplant patients [28] have both correlated with improved kid-
ney graft acceptance. Our observations that PTEC-expressed sHLA-G is partially responsible
for the low HLA-DR and increased IL-10 by our PTEC-MoDC may provide a mechanistic
answer to the findings in those studies.
Collectively, our results confirm that primary human PTEC are able to modulate autologous
APC phenotype and function via multiple complex interactive pathways including
PTEC-PD-L1 induction of MoDC PD-L1; IDO maintenance of CD14 and induction of CD80,
PD-L1 and IL-10 expression on MoDC; and sHLA-G inhibition of HLA-DR up-regulation and
induction of IL-10 expression from MoDC. In–vivo these pathways may be cumulative, with
the net outcome on DC functional response dependent upon multiple factors including the
stage of the disease process, functional competency of the resident PTEC, the cytokine milieu
present within the interstitium and the developmental/activation stage of responding DC.
Overall however, we believe these mechanisms have evolved to enable PTEC to act as negative
regulatory cells to down-modulate DC function within the early inflammatory setting and to
control unrestrained inflammation.
Further dissection of these pathways should enable the development of novel immunother-
apy strategies for the treatment of inflammatory chronic kidney disease.
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